Increased serum SOD1 concentration per 1 pg/mL and SOD2 per 1 ng/mL were significantly associated with a 0.4 and 19% higher HR, respectively, for all-cause mortality in lung cancer patients. This evidence concerns the gene SOD2 and lung carcinoma.